Epstein-Barr Virus (EBV) infection – the infection pathogen behind so-called 'glandular fever' – is a risk factor for multiple sclerosis (MS), but the exact mechanisms involved have been ...

With the rate of diabetes growing worldwide, it can feel like the condition is tough to avoid. A large Japanese study reveals ...

The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...

By addressing this key driver of inflammation, CIT-013 has the potential to offer a differentiated and comprehensive treatment option for conditions such as rheumatoid arthritis and hidradenitis ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology company specializing in the development of allogeneic CAR T cell therapies, stands at a critical juncture in its journey to bring innovative ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...

A team from Osaka University has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously ...